{"doi":"10.21203/rs.3.rs-41273/v1","title":"A role for B cells to transmit hepatitis C virus infection","abstract":"Abstract Hepatitis C virus (HCV) is highly variable and transmits through infected blood to establish a chronic liver infection in the majority of patients. Our knowledge of the infectivity of clinical HCV strains is hampered by the lack of in vitro cell culture systems that support efficient viral replication. We previously reported that laboratory strains of HCV associated with non-permissive B cells could trans-infect hepatocytes and thereby evade host neutralizing antibody responses, suggesting a role for B cells in HCV transmission. To evaluate this hypothesis, we assessed the ability of B cells and sera from recent (&lt;2 years) or chronic (≥ 2 years) infections to infect humanized liver chimeric mice. HCV was efficiently transmitted by B cells from chronically infected patients whereas the sera were non-infectious. In contrast, we noted that B cells from recently infected patients failed to transmit HCV to the mice, whereas all serum samples were infectious. Only patients with circulating anti-glycoprotein antibodies harbored genomic HCV-RNA in B cells. Taken together, our studies provide direct in vivo evidence for HCV transmission by B cells and these findings may have clinical implications for prophylactic and therapeutic antibody-based vaccine design.","journal":"Research Square","year":2020,"id":134264,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9505,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2020-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":590202,"name":"Freya Van Houtte","orcid":null,"position":1,"is_corresponding":false},{"id":590203,"name":"Ali Farhoudi","orcid":null,"position":2,"is_corresponding":false},{"id":589994,"name":"Lieven Verhoye","orcid":"0000-0001-8216-5578","position":3,"is_corresponding":false},{"id":590204,"name":"Caroline Buysschaert","orcid":null,"position":4,"is_corresponding":false},{"id":590205,"name":"Yvonne Gijbels","orcid":null,"position":5,"is_corresponding":false},{"id":590206,"name":"Sibyl Couvent","orcid":null,"position":6,"is_corresponding":false},{"id":590207,"name":"Wilfried Swinnen","orcid":null,"position":7,"is_corresponding":false},{"id":589995,"name":"Hans Van Vlierberghe","orcid":"0000-0003-0647-9238","position":8,"is_corresponding":false},{"id":590208,"name":"A Elewaut","orcid":null,"position":9,"is_corresponding":false},{"id":260259,"name":"Zania Stamataki","orcid":"0000-0003-3823-4497","position":10,"is_corresponding":false},{"id":572177,"name":"Philip Meuleman","orcid":"0000-0001-6821-234X","position":11,"is_corresponding":false},{"id":461249,"name":"Jane A. McKeating","orcid":"0000-0002-7229-5886","position":12,"is_corresponding":false},{"id":589996,"name":"Geert Leroux‐Roels","orcid":"0000-0001-5968-2542","position":13,"is_corresponding":false},{"id":589993,"name":"Isabelle Desombere","orcid":"0000-0003-3521-7712","position":0,"is_corresponding":true}],"reference_count":63,"raw_metadata":null,"created_at":"2026-07-18T23:16:24.540681Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}